Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 28, 2026

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

Reconstructing tumor-wise protein expression in tissue microarray studies using a Bayesian cell mixture model.

Ronglai Shen1, Jeremy M G Taylor, Debashis Ghosh

  • 1Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. shenr@mskcc.org

Bioinformatics (Oxford, England)
|October 17, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Frailty phenotype transitions and functional improvements during a supervised exercise trial in older people with HIV: results from the HEALTH Trial.

Age and ageing·2026
Same author

Glycemic response trajectories on metformin monotherapy in real-world diabetes care.

medRxiv : the preprint server for health sciences·2026
Same author

Robust ranking of renewable energy alternatives handling uncertainty using novel hesitant bi-fuzzy MEREC-MOORA and Dombi aggregation approach.

Scientific reports·2026
Same author

The Impact of Social Vulnerability on Exercise Outcomes: A Longitudinal Study of Physical Function in Older People With HIV.

Journal of the International Association of Providers of AIDS Care·2026
Same author

Special issue: cell and gene causal inference in the design and analysis of gene therapy clinical trials.

Journal of biopharmaceutical statistics·2026
Same author

Mapping the last mile: Micro-stratification for sustained visceral leishmaniasis elimination in Bangladesh.

PLoS neglected tropical diseases·2026
Same journal

Cross-Domain Transfer Learning from Peptides to Metabolites Using a Multi-Property Fine-Tuned LLM.

Bioinformatics (Oxford, England)·2026
Same journal

Biomedical Concept Recognition with Error-aware Negative-enhanced Ranking Framework.

Bioinformatics (Oxford, England)·2026
Same journal

TEDLH: Domain HMMs for sensitive detection of remote homologues.

Bioinformatics (Oxford, England)·2026
Same journal

PLNFGL: Joint Estimation of Multi-Condition Gene Networks from Single-cell RNA-seq Data.

Bioinformatics (Oxford, England)·2026
Same journal

MCFST: Spatial domain identification method based on multi-view graph convolutional network and graph fusion network.

Bioinformatics (Oxford, England)·2026
Same journal

SpaBiT: Enhancing Spatial Transcriptomics Resolution via Bidirectional Attention Transformers.

Bioinformatics (Oxford, England)·2026
See all related articles

A new cell mixture model (CMM) reconstructs tumor expression patterns from tissue microarrays (TMAs). This approach enhances cancer biomarker analysis by providing detailed staining characteristics linked to patient survival outcomes.

Area of Science:

  • Biostatistics
  • Computational Biology
  • Cancer Research

Background:

  • Tissue microarrays (TMAs) are crucial for quantifying cancer biomarker protein expression using immuno-histochemical staining.
  • Current analysis methods often simplify tumor expression by using a sample mean, overlooking complex staining patterns within TMAs.

Purpose of the Study:

  • To introduce a novel cell mixture model (CMM) for reconstructing detailed tumor expression patterns in TMA experiments.
  • To develop a statistical framework that integrates expression data with patient survival outcomes.

Main Methods:

  • A cell mixture model (CMM) aggregates expression patterns from needle biopsy specimens.
  • A zero-augmented Gamma distribution models staining and non-staining areas within tissue elements.

More Related Videos

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
08:14

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry
06:51

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry

Published on: November 14, 2025

Related Experiment Videos

Last Updated: Jun 28, 2026

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
08:14

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry
06:51

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry

Published on: November 14, 2025

  • A hierarchical Bayes model enhances data by borrowing strength across specimens and tumors.
  • A joint model links CMM expression with survival analysis for censored data, using MCMC and Monte Carlo integration.

    • Main Results:

    • The CMM approach yields estimates for tumor expression characteristics, including staining percentage and mean intensity.
    • These detailed expression metrics can be associated with patient survival outcomes.
    • The model provides a more comprehensive understanding of tumor heterogeneity in TMAs.

    Conclusions:

    • The proposed cell mixture model offers a robust method for analyzing complex tissue microarrays.
    • This advanced analysis of cancer biomarker expression can improve patient stratification and survival prediction.
    • An R package for fitting the CMM model is available for broader application.